vs

Side-by-side financial comparison of Ball Corporation (BALL) and Emerson Electric (EMR). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $3.3B, roughly 1.3× Ball Corporation). Emerson Electric runs the higher net margin — 13.9% vs 6.0%, a 7.9% gap on every dollar of revenue. On growth, Ball Corporation posted the faster year-over-year revenue change (16.2% vs 4.1%). Ball Corporation produced more free cash flow last quarter ($1.0B vs $602.0M). Over the past eight quarters, Ball Corporation's revenue compounded faster (7.9% CAGR vs -0.3%).

Ball Corporation is a leading global provider of innovative, sustainable aluminum packaging solutions for beverage, personal care, and household product brands. It also operates an aerospace segment that delivers advanced technologies, systems, and services to government and commercial customers worldwide, prioritizing environmental responsibility and product reliability across all operations.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

BALL vs EMR — Head-to-Head

Bigger by revenue
EMR
EMR
1.3× larger
EMR
$4.3B
$3.3B
BALL
Growing faster (revenue YoY)
BALL
BALL
+12.1% gap
BALL
16.2%
4.1%
EMR
Higher net margin
EMR
EMR
7.9% more per $
EMR
13.9%
6.0%
BALL
More free cash flow
BALL
BALL
$439.0M more FCF
BALL
$1.0B
$602.0M
EMR
Faster 2-yr revenue CAGR
BALL
BALL
Annualised
BALL
7.9%
-0.3%
EMR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BALL
BALL
EMR
EMR
Revenue
$3.3B
$4.3B
Net Profit
$200.0M
$605.0M
Gross Margin
53.2%
Operating Margin
7.2%
17.8%
Net Margin
6.0%
13.9%
Revenue YoY
16.2%
4.1%
Net Profit YoY
766.7%
3.4%
EPS (diluted)
$0.73
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BALL
BALL
EMR
EMR
Q4 25
$3.3B
$4.3B
Q3 25
$3.4B
$4.9B
Q2 25
$3.3B
$4.6B
Q1 25
$3.1B
$4.4B
Q4 24
$2.9B
$4.2B
Q3 24
$3.1B
$4.6B
Q2 24
$3.0B
$4.4B
Q1 24
$2.9B
$4.4B
Net Profit
BALL
BALL
EMR
EMR
Q4 25
$200.0M
$605.0M
Q3 25
$321.0M
$637.0M
Q2 25
$215.0M
$586.0M
Q1 25
$179.0M
$485.0M
Q4 24
$-30.0M
$585.0M
Q3 24
$199.0M
$996.0M
Q2 24
$159.0M
$329.0M
Q1 24
$3.7B
$501.0M
Gross Margin
BALL
BALL
EMR
EMR
Q4 25
53.2%
Q3 25
51.9%
Q2 25
52.6%
Q1 25
53.5%
Q4 24
53.5%
Q3 24
17.7%
51.3%
Q2 24
16.5%
52.8%
Q1 24
16.6%
52.2%
Operating Margin
BALL
BALL
EMR
EMR
Q4 25
7.2%
17.8%
Q3 25
11.6%
16.4%
Q2 25
8.0%
16.1%
Q1 25
7.4%
14.2%
Q4 24
0.2%
18.6%
Q3 24
7.4%
14.7%
Q2 24
6.8%
10.4%
Q1 24
6.8%
16.2%
Net Margin
BALL
BALL
EMR
EMR
Q4 25
6.0%
13.9%
Q3 25
9.5%
13.1%
Q2 25
6.4%
12.9%
Q1 25
5.8%
10.9%
Q4 24
-1.0%
14.0%
Q3 24
6.5%
21.6%
Q2 24
5.4%
7.5%
Q1 24
128.3%
11.4%
EPS (diluted)
BALL
BALL
EMR
EMR
Q4 25
$0.73
$1.07
Q3 25
$1.18
$1.12
Q2 25
$0.76
$1.04
Q1 25
$0.63
$0.86
Q4 24
$0.23
$1.02
Q3 24
$0.65
$1.74
Q2 24
$0.51
$0.57
Q1 24
$11.61
$0.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BALL
BALL
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$1.2B
Total DebtLower is stronger
$7.0B
$7.6B
Stockholders' EquityBook value
$5.4B
$20.3B
Total Assets
$19.5B
$41.9B
Debt / EquityLower = less leverage
1.29×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BALL
BALL
EMR
EMR
Q4 25
$1.2B
Q3 25
$568.0M
Q2 25
$296.0M
Q1 25
$449.0M
Q4 24
$885.0M
Q3 24
$1.4B
Q2 24
$1.3B
Q1 24
$1.7B
Total Debt
BALL
BALL
EMR
EMR
Q4 25
$7.0B
$7.6B
Q3 25
$6.9B
$8.9B
Q2 25
$6.5B
$8.3B
Q1 25
$6.1B
$8.2B
Q4 24
$5.3B
$6.6B
Q3 24
$5.4B
$7.7B
Q2 24
$5.5B
$7.1B
Q1 24
$5.5B
$7.6B
Stockholders' Equity
BALL
BALL
EMR
EMR
Q4 25
$5.4B
$20.3B
Q3 25
$5.4B
$20.3B
Q2 25
$5.2B
$19.9B
Q1 25
$5.5B
$19.2B
Q4 24
$5.9B
$20.5B
Q3 24
$6.7B
$21.6B
Q2 24
$6.9B
$20.8B
Q1 24
$7.3B
$20.9B
Total Assets
BALL
BALL
EMR
EMR
Q4 25
$19.5B
$41.9B
Q3 25
$18.7B
$42.0B
Q2 25
$18.6B
$42.5B
Q1 25
$18.0B
$42.0B
Q4 24
$17.6B
$42.6B
Q3 24
$18.8B
$44.2B
Q2 24
$19.0B
$45.6B
Q1 24
$19.9B
$46.4B
Debt / Equity
BALL
BALL
EMR
EMR
Q4 25
1.29×
0.37×
Q3 25
1.26×
0.44×
Q2 25
1.24×
0.42×
Q1 25
1.12×
0.42×
Q4 24
0.91×
0.32×
Q3 24
0.80×
0.36×
Q2 24
0.80×
0.34×
Q1 24
0.76×
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BALL
BALL
EMR
EMR
Operating Cash FlowLast quarter
$1.2B
$699.0M
Free Cash FlowOCF − Capex
$1.0B
$602.0M
FCF MarginFCF / Revenue
31.1%
13.9%
Capex IntensityCapex / Revenue
5.1%
2.2%
Cash ConversionOCF / Net Profit
6.05×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$788.0M
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BALL
BALL
EMR
EMR
Q4 25
$1.2B
$699.0M
Q3 25
$384.0M
$3.1B
Q2 25
$332.0M
$1.1B
Q1 25
$-665.0M
$241.0M
Q4 24
$500.0M
$777.0M
Q3 24
$610.0M
$3.3B
Q2 24
$252.0M
$1.1B
Q1 24
$-1.2B
$743.0M
Free Cash Flow
BALL
BALL
EMR
EMR
Q4 25
$1.0B
$602.0M
Q3 25
$257.0M
$2.7B
Q2 25
$236.0M
$977.0M
Q1 25
$-746.0M
$154.0M
Q4 24
$393.0M
$694.0M
Q3 24
$493.0M
$2.9B
Q2 24
$146.0M
$998.0M
Q1 24
$-1.4B
$661.0M
FCF Margin
BALL
BALL
EMR
EMR
Q4 25
31.1%
13.9%
Q3 25
7.6%
54.9%
Q2 25
7.1%
21.5%
Q1 25
-24.1%
3.5%
Q4 24
13.6%
16.6%
Q3 24
16.0%
63.1%
Q2 24
4.9%
22.8%
Q1 24
-48.7%
15.1%
Capex Intensity
BALL
BALL
EMR
EMR
Q4 25
5.1%
2.2%
Q3 25
3.8%
8.9%
Q2 25
2.9%
2.0%
Q1 25
2.6%
2.0%
Q4 24
3.7%
2.0%
Q3 24
3.8%
9.1%
Q2 24
3.6%
2.1%
Q1 24
5.4%
1.9%
Cash Conversion
BALL
BALL
EMR
EMR
Q4 25
6.05×
1.16×
Q3 25
1.20×
4.86×
Q2 25
1.54×
1.83×
Q1 25
-3.72×
0.50×
Q4 24
1.33×
Q3 24
3.07×
3.35×
Q2 24
1.58×
3.31×
Q1 24
-0.34×
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BALL
BALL

Transferred Over Time$2.7B82%
Transferred At Point In Time$602.0M18%

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons